期刊文献+

人羊水间充质干细胞对膜性肾病大鼠的治疗作用

Therapeutic effect of human amniotic fluid-derived mesenchymal stem cells on membranous nephropathy in rats
原文传递
导出
摘要 目的研究人羊水间充质干细胞(AF-MSC)对膜性肾病大鼠的治疗作用。方法24只健康雄性SD大鼠随机分为正常对照组(Control组)、模型组(Model组)和AF-MSC治疗组(AF-MSC组),每组8只。在模型组和AF-MSC组注射羊抗大鼠Fx1A抗体构建膜性肾病大鼠模型。造模成功后连续4周尾静脉注射AF-MSC;每周检测大鼠尿蛋白/肌酐比值(UPCR);治疗结束后,腹主动脉取血检测血清肌酐(Scr)、血尿素氮(BUN)、白蛋白(Alb)、甘油三酯(TG)、总胆固醇(TC);肾脏组织切片经马松(Masson)和过碘酸-六胺银(PASM)染色,光镜下观察病理变化;透射电镜观察足细胞和基底膜结构变化;免疫荧光测定各组肾脏组织中IgG、膜攻击复合物C5b-9表达。免疫组织化学观测足细胞nephrin、podocin表达。结果与模型组相比,AF-MSC治疗组UPCR在第4周时显著下降(P<0.01)。血清白蛋白升高和胆固醇下降(均P<0.05);病理结果显示肾小球基底膜免疫复合物沉积减少,基底膜增厚程度减少,足细胞形态相对完好;免疫荧光结果显示IgG和C5b-9沉积减弱;免疫组化结果显示AF-MSC组足细胞中nephrin及podocin蛋白表达增强(P<0.01)。结论AF-MSC可以明显改善膜性肾病大鼠的肾脏损伤。 Objective To investigate the therapeutic effect of human amniotic fluid-derived mesenchymal stem cells(AF-MSC)on membranous nephropathy in rats.Methods Twenty-four healthy male Sprague-Dawley(SD)rats were randomly divided into three groups with 8 rats each.The rat model of membranous nephropathy was established by injection of sheep anti-rat Fx1A antibody in both the model group and AF-MSC group.AF-MSC was injected by tail vein(4×106/rat/week)for 4 weeks after model establishment.The urinary protein/creatinine ratio(UPCR)was measured weekly.After the treatment,serum creatinine(Scr),blood urea nitrogen(BUN),albumin(Alb),triglyceride(TG)and total cholesterol(TC)were detected with blood samples from abdominal aorta of rats.The kidney tissues were stained with the Masson and periodic acid-silver methenamine(PASM)staining methods,and the pathological changes were observed under light microscope.The structural changes of podocytes and basement membrane were observed by transmission electron microscope.The expression of IgG and membrane attack complex C5b-9 in renal tissues in each group were determined by immunofluorescence.The expressions of nephrin and podocin in podocytes were observed by immunohistochemistry.Results Compared with the model group,the AF-MSC group showed significantly lower level of UPCR at week 4(P<0.01),as well as higher level of serum Alb(P<0.05)and lower level of TC(P<0.05).The pathological results showed that the immune complex deposition on glomerular basement membrane was reduced,and that basement membrane thickening was inhibited,with the morphology of podocytes being relatively intact.Immunofluorescence results showed less deposition of IgG and C5b-9 immune complex.Immunohistochemical results showed that the expressions of nephrin and podocin in podocytes were increased(P<0.01).Conclusion The human AF-MSC could effectively alleviate the kidney injury in the membranous nephropathy of the rats.
作者 杨蕴钊 周诚 石美涵 赵静 白雪源 Yang Yunzhao;Zhou Cheng;Shi Meihan;Zhao Jing;Bai Xueyuan(Chinese PLA Medical School,Beijing 100853,China;Department of Nephrology,First Medical Center of Chinese PLA General Hospital,Chinese PLA Institute of Nephrology,State Key Laboratory of Kidney Diseases,National Clinical Research Center for Kidney Diseases,Beijing Key Laboratory of Kidney Diseases,Beijing 100853,China)
出处 《中华肾病研究电子杂志》 2023年第4期181-186,共6页 Chinese Journal of Kidney Disease Investigation(Electronic Edition)
基金 国家重点研发计划项目(2020YFA0113004) 国家自然科学基金重点项目(81830060)。
关键词 人羊水间充质干细胞 膜性肾病 大鼠 Human amniotic fluid-derived mesenchymal stem cells Membranous nephropathy Rat
  • 相关文献

参考文献1

二级参考文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部